Press Releases Arena Pharmaceuticals BOERSE MUENCHEN

Equities

RN3N

US0400476075

Real-time BOERSE MUENCHEN Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		+6.47%	+10.37%

2022	Longboard Pharmaceuticals, Inc. and Arena Pharmaceuticals, Inc. Executes into Second Amendment to That Certain License Agreement	CI
2022	Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from S&P Biotechnology Select Industry Index	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biopharma Stocks Targeting Crohn's Disease In $13.7 Billion Market (STAB, ARNA, GILD and RDHL)	22-03-16	AQ
Pfizer Completes Acquisition of Arena Pharmaceuticals	22-03-14	AQ
Arena Pharmaceuticals : Completion of Acquisition or Disposition of Assets - Form 8-K	22-03-11	PU
ARENA PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	22-03-11	AQ
ARENA PHARMACEUTICALS INC : Other Events (form 8-K)	22-03-10	AQ
ARENA PHARMACEUTICALS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	22-02-23	AQ
Arena Pharmaceuticals : Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates - Form 8-K	22-02-23	PU
Arena Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates	22-02-23	BU
ARENA PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(4)	22-02-18	AQ
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	22-02-17	BU
Pfizer's announced purchase of Arena Pharmaceuticals exemplifies a satisfactory acquisition within the CBD medical treatment industry	22-02-15	AQ
Arena Pharmaceuticals to Release Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update on February 23	22-02-09	BU
ARENA PHARMACEUTICALS INC : Other Events (form 8-K)	22-02-07	AQ
ARENA PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-K)	22-02-02	AQ
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)	22-01-19	AQ
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	22-01-18	BU
ARENA PHARMACEUTICALS INC : Other Events (form 8-K)	22-01-07	AQ
ARENA PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(4)	21-12-22	AQ
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	21-12-21	BU
Harley-Davidson, Arena rise; Capital One, Carnival fall	21-12-13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Arena Pharmaceuticals BOERSE MUENCHEN

Equities

RN3N

US0400476075

Press Releases

Filters